Encorafenib, Binimetinib, and Cetuximab in BRAF V600E–Mutated Colorectal Cancer
Original Article
S. Kopetz, A. Grothey, R. Yaeger, E.V. Cutsem, J. Desai, T. Yoshino, H. Wasan, F. Ciardiello, F. Loupakis, Y.S. Hong, N. Steeghs, T.K. Guren, H.-T. Arkenau, P. Garcia-Alfonso, P. Pfeiffer, S. Orlov, S. Lonardi, E. Elez, T.-W. Kim, J.H. Schellens, C. Guo, A. Krishnan, J. Dekervel, V. Morris, A.C. Ferrandiz, L. Tarpgaard, M. Braun, A. Gollerkeri, C. Keir, K. Maharry, M. Pickard, J. Christy-Bittel, L. Anderson, V. Sandor, and J. Tabernero
N Engl J Med 2019;381:1632-1643
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Course closed
This course closed on Sunday, October 24, 2021 - 11:59pm.